2013 annual financial data
BioMarin Pharmaceutical 2013 Operating cash flow margin
Direct answer
Operating cash flow margin was -10.87%.
Operating income was -156,007,000 USD and net income was -176,353,000 USD.
Operating cash flow was -59,634,000 USD.
Get free BioMarin Pharmaceutical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 548,485,000 USD
- Operating income
- -156,007,000 USD
- Net income
- -176,353,000 USD
- Operating cash flow
- -59,634,000 USD